The U.S. Food and Drug Administration (FDA) meets this week to review the safety of metal-on-metal hip implants even as the agency reports that adverse events related to these medical devices skyrocketed during the last decade.
More than 40 serious adverse effects on the skin have been linked to the osteoporosis drugProlia (denosumab), according to a review of Food and Drug Administration records by investigators.